SCHEMBL1703017

SCHEMBL1703017

COc1ccc(-c2cc(C(C)(C)C)c(OC)c3cc(N4CCC(CNS(C)(=O)=O)C4)cnc23)c(=O)[nH]1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK1 P51617 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
ALOX15 P16050 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
GAA P10253 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
AURKA O14965 2/20 0.33
AURKB Q96GD4 2/20 0.33
ENPP1 P22413 3/20 0.33
SMO Q99835 1/20 0.33
GAK O14976 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
DDR1 Q08345 2/20 0.32
RBP4 P02753 2/20 0.32
TTR P02766 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2452207 1.00 IRAK1 (0.35) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL2448595 0.93 AURKA (0.36) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL1703312 0.91 IRAK1 (0.34) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL2452968 0.91 IRAK1 (0.34) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL2451535 0.89 MAPT (0.38) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL3796409 0.88 CYP3A4 (0.40) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL2448864 0.88 CYP3A4 (0.40) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL1702751 0.88 IRAK1 (0.36) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL1702753 0.88 IRAK1 (0.36) IRAK1KDM4EALDH1A1MAPTALOX15
SCHEMBL3759266 0.85 IRAK1 (0.37) IRAK1KDM4EALDH1A1MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440528-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-04-18 EP disclosed
WO-2010142656-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-12-16 WO disclosed